Detalles de la búsqueda
1.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314967
2.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
Rheumatology (Oxford)
; 61(12): 4741-4751, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323903
3.
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
Rheumatology (Oxford)
; 61(9): 3799-3807, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940840
4.
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Ann Rheum Dis
; 80(11): 1400-1409, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926921
5.
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis.
Rheumatology (Oxford)
; 60(SI): SI3-SI12, 2021 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34146099
6.
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
Rheumatology (Oxford)
; 59(9): 2455-2461, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31960053
7.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31665497
8.
CT-guided transarticular biopsy of the sacroiliac joint: Technique and histomorphological results. A preliminary study.
Skeletal Radiol
; 49(3): 453-460, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31485679
9.
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Ann Rheum Dis
; 78(2): 192-200, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396903
10.
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ann Rheum Dis
; 78(11): 1536-1544, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31431486
11.
Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
Scand J Clin Lab Invest
; 78(6): 483-489, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30176763
12.
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Ann Rheum Dis
; 76(8): 1426-1431, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28473425
13.
Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity.
Clin Exp Rheumatol
; 35(4): 653-659, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28240584
14.
Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry.
Rheumatology (Oxford)
; 55(4): 659-68, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26628579
15.
Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.
Rheumatol Int
; 36(4): 541-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26620690
16.
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries.
Ann Rheum Dis
; 79(6): 846-848, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32111583
17.
Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registry.
Ann Rheum Dis
; 74(12): 2130-6, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25063827
18.
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.
Ann Rheum Dis
; 79(2): e14, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573653
19.
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.
Ann Rheum Dis
; 79(4): e37, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674476
20.
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.
Rheumatology (Oxford)
; 53(11): 2100-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24939677